Dubai Derma 2025: EG Bio Strengthens Partnerships Across The Middle East

From April 14 to 16, 2025, EG Bio participated in Dubai Derma 2025 alongside Genèse Labs France, strengthening engagement across Middle Eastern markets.

Dubai Derma is the largest dermatology and aesthetic exhibition in the Middle East, typically attracting 20,000+ visitors, 1,500+ brands, and professionals from 100+ countries. The exhibition plays a central role in shaping regional distribution frameworks, regulatory pathways, and commercial partnerships.

At Dubai Derma 2025, EG Bio and Genèse Labs France presented their latest injectable, biostimulator, and regenerative solutions. Discussions with regional distributors focused on portfolio expansion, regulatory considerations, and market-specific strategies for GCC and MENA markets.

About EG Bio

EG Bio Co., Ltd. is a global B2B supplier and distribution partner specializing in professional aesthetic products. The company works with selected international brands and manufacturers to support structured global distribution, market development, and long-term partnerships across multiple regions.

EG Bio focuses on exclusive distribution models, portfolio expansion, and international market access, providing distributors and professional partners with reliable supply, clear positioning, and sustainable growth opportunities.

About Genèse Labs France

Genèse Labs France is a France-based company focused on the development and management of aesthetic and dermocosmetic product portfolios for professional markets. The company works with selected manufacturing and distribution partners to support structured international expansion, emphasizing product quality, regulatory alignment, and long-term brand development.

Genèse Labs France positions its products for global markets through strategic partnerships, ensuring clear brand ownership, consistent positioning, and sustainable growth across multiple regions.